目次

TABLE OF CONTENT

1 Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.2.1 Key Inclusions & Exclusions
1.3 Research Scope
1.3.1 Segments Covered
1.3.2 Geographic Scope
1.3.3 Years Considered For the Study
1.4 Currency Used For the Study
1.5 Major Market Stakeholders
1.6 Summary of Changes
1.6.1 Recession Impact

2 Research Methodology
2.1 Research Data Sources
2.1.1 Secondary Data
2.1.2 Primary Data
2.2 Market Size Estimation Methodology
2.3 Market Share Estimation Methodology
2.4 Market Break Down and Data Triangulation
2.5 Research Assumptions
2.6 Research Limitations
2.6.1 Scope Related Limitations
2.6.2 Methodology Related Limitations
2.7 Recession Impact Assessment Approach
2.8 Risk Assessment

3 Executive Summary

4 Premium Insights

5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Major Drivers
5.2.2 Key Restraints
5.2.3 Key Growth Opportunities
5.2.4 Industry-Specific Challenges
5.3 Regulatory Landscape
5.3.1 Regulatory Bodies, Government Agencies and Other Organizations
5.3.2 Regulatory Analysis
5.4 Value Chain Analysis
5.5 Supply Chain Analysis
5.6 Ecosystem Market Map
5.7 Technology Analysis
5.8 Trade Data Analysis
5.9 Patent Analysis
5.10 Porter’s Five Force Analysis
5.11 Pricing Analysis
5.11.1 Average Selling Price of Key Players By Product
5.11.2 Average Selling Price Trends
5.12 Case Study Analysis
5.13 Key Conferences and Events In 2022-23
5.14 Key Stakeholders and Buying Criteria
5.14.1 Key Stakeholders and Buying Criteria
5.14.2 Buying Criteria

6 Breast Biopsy Devices Market, By Type (USD Million; 2021—2028)*
6.1 Introduction
6.2 Biopsy Needles
6.3 Guidance Systems
6.4 Biopsy Tables
6.5 Localization Wires
6.6 Assay Kits
6.7 Liquid Biopsy Instruments
6.8 Other Devices

7 Breast Biopsy Devices Market, By Procedure (USD Million; 2021—2028)*
7.1 Introduction
7.2 Needle Breast Biopsy
7.2.1 Core-Needle Biopsy (CNB)
7.2.2 Fine-Needle Aspiration Biopsy (FNAB)
7.2.3 Vacuum-Assisted Biopsy (VAB)
7.3 Open Surgical Breast Biopsy
7.3.1 Excisional
7.3.2 Incisional
7.4 Liquid Breast Biopsy
7.4.1 Circulating Tumor Cells (CTC)
7.4.2 Circulating Tumor CNA (CtDNA)
7.4.2 Other Biomarkers

8 Breast Biopsy Devices Market, By Technique (USD Million; 2021—2028)*
8.1 Introduction
8.2 Image Guided Biopsy
8.2.1 Mammography-Guided/Stereotactic
8.2.2 Ultrasound-Guided
8.2.3 MRI-Guided
8.2.3 Other Image-Guided Techniques
8.3 Liquid Biopsy
8.3.1 NGS Based Biopsy
8.3.2 PCR Based Biopsy
8.3.3 Microarray Based Biopsy

9 Breast Biopsy Devices Market, By Application (USD Million; 2021—2028)*
9.1 Introduction
9.2 Early Cancer Screening
9.3 therapy Selection
9.4 Treatment Monitoring
9.5 Recurrence Monitoring

10 Breast Biopsy Devices Market, By End-User (USD Million; 2021—2028)*
10.1 Introduction
10.2 Hospitals & Surgical Centers
10.3 Breast Care Centers
10.4 Imaging Clinics & Diagnostic Centers

11 Breast Biopsy Devices Market, By Region (USD Million; 2021—2028)*
11.1 North America
11.1.1 Recession Impact
11.1.2 US
11.1.3 Canada
11.2 Europe
11.2.1 Recession Impact
11.2.2 Germany
11.2.3 UK
11.2.4 France
11.2.5 Italy
11.2.6 Spain
11.2.7 Rest of Europe
11.3 Asia-Pacific
11.3.1 Recession Impact
11.3.2 Japan
11.3.3 China
11.3.4 India
11.3.5 South Korea
11.3.6 Australia
11.3.7 Rest of Asia-Pacific
11.4 Latin America
11.4.1 Recession Impact
11.4.2 Brazil
11.4.3 Mexico
11.4.4 Rest of Latin America
11.5 Middle East and Africa
11.5.1 Recession Impact

12 Competitive Landscape
12.1 Overview
12.2 Revenue Share Analysis of Key Players (2022)
12.3 Market Share Analysis For Top 5 Global Players (In Terms of %Revenue, In 2022)
12.4 Company Footprint Analysis
12.5 Competitive Benchmarking
12.6 Competitive Situation and Trends (2021-2023)
12.6.1 Product Launches and Approvals
12.6.2 Deals
12.7 Company Evaluation Quadrant
12.7.1 Pervasive Players
12.7.2 Emerging Leaders
12.7.3 Participants
12.7.4 Stars
12.8 SME/Start-Up Evaluation Quadrant
12.8.1 Progressive Companies
12.8.2 Responsive Companies
12.8.3 Dynamic Companies
12.8.4 Starting Blocks
12.9 Key Players Strategies-Right To Win

13 Company Profiles**
13.1 Major Players
13.1.1 Hologic Inc.
13.1.2 Danaher Corporation
13.1.3 Becton, Dickinson and Company
13.1.4 Argon Medical Devices
13.1.5 Guardant Health, Inc.
13.1.6 Merit Medical Systems
13.1.7 Menarini-Silicon Biosystems
13.1.8 NeoGenomics
13.1.9 Sysmex Inostics
13.1.10 Sterylab S.R.L.
13.1.11 Biocept, Inc.
13.1.12 Bio-Rad Laboratories, Inc.
13.1.13 F. Hoffmann-La Roche Ltd
13.1.14 Qiagen
13.1.15 Exact Sciences Corporation
13.2 Other Players
13.2.1 Thermo Fisher Scientific
13.2.2 Cardiff Oncology Inc.
13.2.3 Myriad Genetics, Inc.
13.2.4 Illumina, Inc
13.2.5 Fluxion Biosciences, Inc.
13.2.6 Fujifilm Holdings Corporation
13.2.7 Inrad, Inc.
13.2.8 IZI Medical Products
13.2.9 Remington Medical Inc.
13.2.10 CP Medical

14 Appendix
14.1 Discussion Guide
14.2 Knowledge Store: Marketsandmarkets’ Subscription Portal
14.3 Available Customizations
14.4 Related Reports
14.5 Author Details